Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options

被引:20
|
作者
Di Lullo, Luca [1 ]
Ronco, Claudio [2 ]
Granata, Antonio [3 ,4 ]
Paoletti, Ernesto [5 ]
Barbera, Vincenzo [1 ]
Cozzolino, Mario [6 ]
Ravera, Maura [5 ]
Fusaro, Maria [7 ]
Bellasi, Antonio [8 ]
机构
[1] L Parodi Delfino Hosp, Dept Nephrol & Dialysis, Colleferro, Italy
[2] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy
[3] S Giovanni di Dio Hosp, Dept Nephrol & Dialysis, Agrigento, Italy
[4] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy
[5] San Martino Hosp, Dept Nephrol & Dialysis, Genoa, Italy
[6] S Paolo Hosp, Dept Hlth Sci, Milan, Italy
[7] Univ Padua, Dept Med, Padua, Italy
[8] St Anna Hosp, ASTT Lariana, Dept Nephrol & Dialysis, Como, Italy
关键词
Hyperkalemia; Chronic kidney disease; Heart failure; Renin-angiotensin-aldosterone system inhibitors; Potassium binder; CHRONIC KIDNEY-DISEASE; SODIUM ZIRCONIUM CYCLOSILICATE; HEART-FAILURE; SERUM POTASSIUM; RENAL-DISEASE; DOUBLE-BLIND; PATIROMER; OUTCOMES; ALDOSTERONE; ASSOCIATION;
D O I
10.1159/000493395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:8 / 21
页数:14
相关论文
共 50 条
  • [1] New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease
    Esposito, Pasquale
    Conti, Novella Evelina
    Falqui, Valeria
    Cipriani, Leda
    Picciotto, Daniela
    Costigliolo, Francesca
    Garibotto, Giacomo
    Saio, Michela
    Viazzi, Francesca
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 17
  • [2] Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
    Morales, Enrique
    Cravedi, Paolo
    Manrique, Joaquin
    FRONTIERS IN MEDICINE, 2021, 8
  • [3] New options for the management of chronic hyperkalemia
    Fried, Linda
    Kovesdy, Csaba P.
    Palmer, Biff F.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2017, 7 (03) : 164 - 170
  • [4] Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
    Alcazar-Arroyo, Roberto
    Crespo-Leiro, Maria G.
    Bover, Jordi
    Oliva, Juan
    Sequera-Mutiozabal, Miren
    Gradari, Simona
    Marinez-Lopez, Anisia
    Lopez-Chicheri, Blanca
    Vidal-Vilar, Neus
    Aceituno, Susana
    Cobo, Marta
    NEFROLOGIA, 2024, 44 (05): : 709 - 720
  • [5] A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database
    Sharma, Ajay
    Alvarez, Paula J.
    Woods, Steven D.
    Dai, Dingwei
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 657 - 667
  • [6] Ramipril and Risk of Hyperkalemia in Chronic Hemodialysis Patients
    Krajina-Andricevic, Mirna
    Zibar, Lada
    Juras, Karin
    Goll-Baric, Sanda
    Barbic, Jerko
    COLLEGIUM ANTROPOLOGICUM, 2011, 35 (02) : 537 - 542
  • [7] A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
    Ramon Gonzalez-Juanatey, Jose
    Gonzalez-Franco, Alvaro
    de Sequera, Patricia
    Valls, Marta
    Ramirez de Arellano, Antonio
    Pomares, Elisenda
    Nieves, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 640 - 649
  • [8] Treatment motivation in patients with chronic cardiorenal syndrome
    Efremova, E. V.
    Shutov, A. M.
    Borodulina, E. O.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (12) : 13 - 17
  • [9] Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients
    Cai, Jun-jun
    Wang, Kai
    Jiang, Hui-qing
    Han, Tao
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [10] Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia
    Dong, Lingqiu
    Xu, Weidong
    Deng, Yi
    Tan, Jiaxing
    Qin, Wei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 931